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Abstract Aspergillus mastoidits and skull-base osteomy-
elitis are extremely rare, even in immunocompromised
patients. We report a case of an 81-year-old immunocom-
petent man, who underwent a mastoidectomy because of
unexplained, progressive otalgia in spite of a noninXamed
and air-containing middle-ear space. Histopathology
yielded Aspergillus fumigatus. When confronted with otitis
with an unexpected clinical course a high index of suspi-
cion is required to facilitate early diagnosis and appropriate
therapy of a potential lethal Aspergillus infection, even in
immunocompetent patients. This seems to be more so in
older patients with an open middle-ear cavity and/or when
there is facial nerve involvement.
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Introduction
Invasive skull-base mastoiditis, also known as malignant or
necrotizing otitis externa, typically aVects immunocompro-
mised patients (diabetes, leukemia, AIDS, prior treatment
with cytotoxic medication and or corticosteroids) and is
usually caused by Pseudomonas aeruginosa.
Although being an uncommon condition, it is often well
recognized and at one moment diVerentiated from an ‘ordi-
nary’ otitis due to alarming (progressive) symptoms such as
extreme/deep otalgia, vertigo-hearing loss (labyrinthitis),
facial nerve dysfunction and sometimes dysfunction of
other nerves of the cerebellopontine angle (Gradenigo syn-
drome).
Although human exposure to Aspergillus is common,
infections are infrequent. Aspergillus mastoiditis and skull-
base osteomyelitis are extremely rare, even in immunocom-
promised patients [5], the Wrst patient being described in
1985 [8]. We report a case of invasive Aspergillus fumiga-
tus skull-base mastoiditis in an immunocompetent patient,
only Wrst recognized at surgery.
Case report
An 81-year-old man presented with a 5-week history of
right-sided otalgia and otorrhoea (Table 1). His hearing in
the right ear was subjectively reduced; there was no history
of tinnitus or vertigo. Examination revealed whitish debris
Wlling the right external auditory canal. The left ear was
normal. His medical history included a symmetrical presby-
acusis, for which he had been wearing hearing aids bilater-
ally since 1999. He did not take any medication. Initially,
the diagnosis of a right-sided external otitis was made and
the patient was treated with oral antibiotics and acetic acid
ear drops.
One month later the patient returned with progressive,
intermittent severe/undurable, right-sided otalgia.
Examination showed some mild otorrhoea as well as a
quiet, central perforation in the tympanic membrane
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with a noninXamed and air-containing middle ear space.
The ear canal was slightly edematous. No granulation tissue
could be seen in the external auditory canal or middle ear
by microscopic examination. There was no post-auricular
Xuctuation and no erythema, tenderness or edema over the
mastoid area. Facial function was normal. The Valsalva
maneuver was negative.
Initial laboratory workup showed signs of an infection
[ESR 46 mm/h, CRP 21.3 mg/l, normal WBC (8.6 £ 109/l;
16% lymphocytes)]. Liver enzymes were normal. Fasting
blood sugar was 6.1 mmol/l. Anti-dsDNA, ENA, anti-pro-
teinase3 and anti-myeloperoxidase were all negative. Tone
and speech audiometry showed a superimposed conductive
hearing loss of the right ear. Because of the ununderstood
invalidating earache (not matching with the quite external
auditory canal, tympanic membrane and middle ear) a com-
puted tomography (CT) scan was planned. This scan
(1 week later) demonstrated complete opaciWcation of the
right mastoid air cells, swelling of the soft tissues surround-
ing the ear but no signs of bony erosion (Fig. 1).
Considering the aforementioned and the still progres-
sive, sometimes undurable otalgia, despite the use of broad
spectrum antibiotics and strong analgesics, we decided to
perform a cortical mastoidectomy to obtain mastoid-mate-
rial for histopathologic investigation.
At surgery subcutaneous edema and a black discolor-
ation of the mastoid cortex and the bony ear canal was
encountered. This was the Wrst time invasive fungal mas-
toiditis or other bone inWltrating pathology was suspected.
Therefore, we decided to perform directly a canal wall
down (radical mastoidectomy) procedure to remove as
much infected bone as possible and to ensure a good
drainage. Purulent Xuid and widespread granulation tissue
Wlled the mastoid air cells. Intraoperative specimens of
tissue were sent for culture and histopathological
analysis.
After surgery an infectious disease consult was obtained
to medically complement surgical eradication of the fungal
infection. Postoperatively, the patient was treated with local
miconazol dressing on cotton strips and oral voriconazol
(200 mg twice daily) for 4 weeks.
Histolopathological analysis revealed necrosis, inXam-
mation/granulocytes, and numerous septate fungal hyphae.
Cultures of mastoid material obtained during surgery
yielded Aspergillus fumigatus.
At follow-up visits after surgery, a well-healed incision
was seen and the mastoid cavity re-epithelialized normally
in several months with no evidence of residual or persistent
disease by microscopic examination (last visit 1 year after
surgery).
Discussion
Mycotic infections of the head and neck region are uncom-
mon. Infections of the external auditory canal and paranasal
sinuses are the most encountered sites.
The classiWcation of Aspergillus infections has been
described for paranasal sinus aspergillosis, and has been
expanded to include temporal bone infection [5].
Documented cases of Aspergillus mastoiditis are exceed-
ingly rare and all but six [1–4, 6, 7] of the reported cases to
date involved immunocompromised patients.
Patients with invasive aspergillosis can have similar
clinical presentation and physical Wndings as an infection
caused by Pseudomonas aeruginosa. Failure to identify
Aspergillus as the causative pathogen of invasive temporal
bone infection is the principal reason for delay in initiating
potentially life-saving therapy.
In our patient mainly the mastoid was involved with the
infection and not so the well-aerated middle ear (Fig. 1). This
Table 1 Visits, Timeline: 
First Symptoms            Visit I          Lab    CT  Operation      Stop voriconazol                Dry and Clean Radical 
Weeks:      0       +5            +4     +1      +1            +4           +52 
Fig. 1 Axial CT scan of the right temporal bone showing complete
opaciWcation of the mastoid air cells, an air-containing middle ear and
swelling of the soft tissues surrounding the earEur Arch Otorhinolaryngol (2009) 266:1655–1657 1657
123
unusual Wnding might be explained with an obstruction of
the aditus ad antrum through pathologic tissue (granulation
tissue) in combination with the tympanic membrane perfo-
ration [10].
Almost all patients with documented invasive external
otitis resulting from Aspergillus reported in literature were
noted to have facial nerve involvement. Evidence of facial
nerve involvement in patients with mastoiditis—particu-
larly those who are immunocompromised and do not
respond to antibiotics—should cause one to consider
Aspergillus in the diVerential diagnosis [1–6, 8].
Another noteworthy co-incidence in the seven
documented immunocompetent patients with Aspergillus
mastoiditis to date (our patient included) is their old age
(52–85, average 75 years) and the fact that they all had a
port d’entrée to the tympanic cavity or mastoid: six had a
tympanic membrane perforation [1–4, 6] and the seventh
(with the age of 52) was already known with a cholestea-
toma (for which she refused surgery) 9 years before the
mastoiditis [7].
Treatment of Aspergillus mastoiditis is threefold.
Aggressive surgical debridement and resection is required
and antifungal therapy should be instituted once the diagno-
sis is made. Hyperbaric oxygen therapy should be consid-
ered post-operative although clear evidence to demonstrate
eVectiveness is still missing [9].
Further, attempt should be made to Wnd and control any
underlying immunologic conditions.
Conclusion
Mastoiditis caused by Aspergillus species is very uncom-
mon. Because of the invasive nature of this life threatening
disease, prompt diagnosis and aggressive management
including surgical debridement and antifungal therapy are
necessary.
When confronted with otitis/ear complaints with an
unexpected clinical course a high index of suspicion is
required to facilitate early diagnosis and appropriate
therapy of a potential lethal Aspergillus infection, even in
immunocompetent patients. This seems the more so in
older patients with an open middle ear cavity (tympanic
membrane perforation, cholesteatoma) and/or when there is
facial nerve involvement.
This is for we know the seventh immunocompetent
patient with invasive Aspergillus mastoiditis described in
the world literature.
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